GSA CAPITAL PARTNERS LLP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,835,000
+671.0%
49,160
+429.1%
0.21%
+428.2%
Q1 2021$238,000
-45.2%
9,291
-52.8%
0.04%
-45.1%
Q4 2020$434,000
-1.1%
19,688
-19.3%
0.07%
-2.7%
Q3 2020$439,000
+133.5%
24,388
+138.5%
0.07%
+55.3%
Q1 2020$188,000
-84.8%
10,225
-81.8%
0.05%
-67.4%
Q4 2019$1,238,00056,1890.14%
Other shareholders

There were no reported owners of DICERNA PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of DICERNA PHARMACEUTICALS INC shareholders